Celltrion (068270)
셀트리온 KOSPI 기초 의약물질 제조업
Close (Aug 19, 2026)
₩194,100
-0.72%
Market cap
₩45T ($32.0B)
52-week range
₩158,500 –
₩239,245
P/E · P/B · Div yield
43.63 · 2.59 ·
0.39%
View chart data as a table
| Date | Close | Foreign net | Institutions | Retail |
|---|---|---|---|---|
| 2026-08-19 | ₩194,100 | +₩1.7bn | ₩-2.1bn | +₩0.1bn |
| 2026-08-18 | ₩195,500 | +₩17.8bn | ₩-20.1bn | +₩3.1bn |
| 2026-08-14 | ₩201,000 | +₩18.6bn | ₩-10.8bn | ₩-10.1bn |
| 2026-08-13 | ₩202,000 | +₩37.7bn | ₩-37.4bn | +₩1.1bn |
| 2026-08-12 | ₩202,000 | ₩-4.5bn | ₩-32.3bn | +₩42.3bn |
| 2026-08-11 | ₩210,500 | +₩132.4bn | +₩11.7bn | ₩-140.3bn |
| 2026-08-10 | ₩201,000 | +₩39.9bn | ₩-0.1bn | ₩-38.8bn |
| 2026-08-07 | ₩199,300 | +₩29.5bn | +₩33.0bn | ₩-61.5bn |
| 2026-08-06 | ₩195,000 | +₩20.5bn | +₩32.6bn | ₩-57.6bn |
| 2026-08-05 | ₩190,300 | +₩42.0bn | +₩6.0bn | ₩-47.4bn |
| 2026-08-04 | ₩185,800 | +₩28.9bn | ₩-10.5bn | ₩-17.7bn |
| 2026-08-03 | ₩182,200 | ₩-9.2bn | ₩-18.0bn | +₩27.5bn |
| 2026-07-31 | ₩186,700 | ₩-12.6bn | ₩-46.4bn | +₩58.3bn |
| 2026-07-30 | ₩190,000 | +₩13.4bn | +₩70.0bn | ₩-83.3bn |
| 2026-07-29 | ₩180,000 | ₩-32.7bn | +₩55.1bn | ₩-54.9bn |
| 2026-07-28 | ₩177,400 | ₩-25.9bn | +₩76.0bn | ₩-49.7bn |
| 2026-07-27 | ₩178,700 | ₩-16.4bn | +₩27.5bn | ₩-11.8bn |
| 2026-07-24 | ₩177,600 | +₩29.2bn | +₩30.0bn | ₩-58.2bn |
| 2026-07-23 | ₩172,200 | +₩16.5bn | ₩-4.9bn | ₩-10.3bn |
| 2026-07-22 | ₩170,100 | +₩13.3bn | ₩-5.8bn | ₩-7.6bn |
| 2026-07-21 | ₩171,600 | +₩9.0bn | +₩1.3bn | ₩-10.1bn |
| 2026-07-20 | ₩172,600 | ₩-5.5bn | +₩4.7bn | +₩2.0bn |
| 2026-07-16 | ₩175,800 | +₩11.3bn | +₩1.1bn | ₩-12.4bn |
| 2026-07-15 | ₩175,700 | +₩25.2bn | ₩-11.9bn | ₩-13.9bn |
| 2026-07-14 | ₩172,800 | +₩4.1bn | +₩18.5bn | ₩-23.2bn |
| 2026-07-13 | ₩175,100 | +₩19.8bn | +₩24.4bn | ₩-43.9bn |
| 2026-07-10 | ₩175,200 | +₩11.3bn | +₩3.6bn | ₩-13.9bn |
| 2026-07-09 | ₩173,100 | ₩-9.9bn | +₩27.2bn | ₩-12.8bn |
| 2026-07-08 | ₩176,800 | +₩1.3bn | +₩34.0bn | ₩-34.3bn |
| 2026-07-07 | ₩178,200 | +₩9.6bn | +₩18.7bn | ₩-43.5bn |
| 2026-07-06 | ₩175,900 | ₩-8.1bn | ₩-10.6bn | +₩16.7bn |
| 2026-07-03 | ₩183,600 | ₩-15.5bn | +₩40.0bn | ₩-37.7bn |
| 2026-07-02 | ₩176,600 | +₩4.2bn | +₩41.7bn | ₩-58.0bn |
| 2026-07-01 | ₩174,500 | ₩-10.8bn | ₩-6.2bn | +₩8.0bn |
| 2026-06-30 | ₩173,300 | ₩-14.7bn | +₩4.6bn | ₩-2.0bn |
| 2026-06-29 | ₩179,200 | +₩6.8bn | +₩42.3bn | ₩-50.3bn |
| 2026-06-26 | ₩165,900 | ₩-12.8bn | +₩2.6bn | +₩2.3bn |
| 2026-06-25 | ₩173,100 | +₩12.0bn | +₩2.8bn | ₩-30.7bn |
| 2026-06-24 | ₩172,700 | +₩30.2bn | +₩0.6bn | ₩-36.6bn |
| 2026-06-23 | ₩160,500 | +₩18.0bn | ₩-6.2bn | ₩-22.5bn |
| 2026-06-22 | ₩168,500 | +₩32.4bn | ₩-27.3bn | ₩-16.1bn |
| 2026-06-19 | ₩170,300 | +₩6.1bn | ₩-8.2bn | ₩-8.1bn |
| 2026-06-18 | ₩173,600 | +₩19.6bn | ₩-18.3bn | ₩-11.8bn |
| 2026-06-17 | ₩174,600 | +₩11.6bn | ₩-10.8bn | ₩-9.9bn |
| 2026-06-16 | ₩174,500 | +₩3.4bn | ₩-2.5bn | ₩-7.8bn |
| 2026-06-15 | ₩175,000 | +₩10.7bn | ₩-14.3bn | ₩-2.3bn |
| 2026-06-12 | ₩173,000 | +₩13.7bn | ₩-1.9bn | ₩-33.6bn |
| 2026-06-11 | ₩166,200 | ₩-0.6bn | ₩-16.5bn | ₩-4.9bn |
| 2026-06-10 | ₩167,300 | ₩-15.6bn | +₩7.7bn | ₩-11.6bn |
| 2026-06-09 | ₩170,000 | +₩14.4bn | +₩6.0bn | ₩-39.7bn |
| 2026-06-08 | ₩159,400 | ₩-6.4bn | ₩-28.2bn | +₩9.0bn |
| 2026-06-05 | ₩171,400 | ₩-20.4bn | ₩-4.4bn | +₩26.2bn |
| 2026-06-04 | ₩176,500 | ₩-25.5bn | +₩2.9bn | +₩22.7bn |
| 2026-06-02 | ₩179,100 | +₩0.1bn | +₩1.9bn | ₩-2.9bn |
| 2026-06-01 | ₩182,722 | +₩17.4bn | +₩0.8bn | ₩-18.8bn |
| 2026-05-29 | ₩183,866 | +₩15.9bn | +₩3.1bn | ₩-19.2bn |
| 2026-05-28 | ₩181,102 | +₩15.0bn | ₩-21.8bn | +₩6.0bn |
| 2026-05-27 | ₩185,391 | +₩16.6bn | ₩-5.1bn | ₩-12.0bn |
| 2026-05-26 | ₩185,867 | ₩-21.9bn | +₩5.0bn | +₩16.8bn |
| 2026-05-22 | ₩189,394 | +₩49.0bn | +₩9.6bn | ₩-59.4bn |
| 2026-05-21 | ₩180,720 | +₩31.7bn | ₩-6.3bn | ₩-25.1bn |
Investor flows summary
| Window | Foreign | (USD) | Institutions | Retail |
|---|---|---|---|---|
| 1 day | +₩1.7bn | +$1M | ₩-2.1bn | +₩0.1bn |
| 5 days | +₩71.3bn | +$51M | ₩-102.7bn | +₩36.6bn |
| 20 days | +₩340.1bn | +$241M | +₩153.5bn | ₩-516.7bn |
Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.
Annual financials
| Fiscal year | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| 2023 | ₩2.2T ($1.5B) | – | ₩651bn ($462M) | ₩540bn ($383M) |
| 2024 | ₩3.6T ($2.5B) | +63.40% | ₩492bn ($349M) | ₩419bn ($297M) |
| 2025 | ₩4.2T ($3.0B) | +17.00% | ₩1.2T ($829M) | ₩1.0T ($732M) |
Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1410.07/$) for reference only.